Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Janssen Research & Development, LLC
This is a phase II, randomized, double-blind, placebo-controlled study of bermekimab in patients with moderate to severe atopic dermatitis. The primary objective of the study is to analyze the safety and efficacy of different dose regimens of bermekimab compared to placebo treatment in adult patients with moderate-to-severe AD. The study is multicenter and will consist of three groups: Treatment Arm 1: Bermekimab every week (qw) Treatment Arm 2: Bermekimab every other week (q2w) Arm 3 (Placebo): Placebo every week (qw)
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
